Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies.
about
Effect of plasmid-mediated stable interferon-γ expression on proliferation and cell death in the SKOV-3 human ovarian cancer cell line.Urinary neopterin levels in patients with thyroid cancerDysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progressionIntravenous ascorbic acid to prevent and treat cancer-associated sepsis?Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.The tryptophan kynurenine pathway, neopterin and IL-6 during vulvectomy and abdominal hysterectomy.Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults.Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.Determination of pteridines in biological samples with an emphasis on their stability.IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor DiseaseSerum Immune System Biomarkers Neopterin and Interleukin-10 Are Strongly Related to Tryptophan Metabolism in Healthy Young Adults.Neopterin as a biomarker of immune response in cancer patients.Evaluating noninvasive markers of nonhuman primate immune activation and inflammation.Serum neopterin as a prognostic indicator in patients with gastric carcinoma.Human epididymis protein 4: the start of a post-ROMAn era?Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO).Neopterin, kynurenine and tryptophan as new biomarkers for early detection of rectal anastomotic leakage.Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis.Association between seminal plasma neopterin and oxidative stress in male infertility: A case-control study.
P2860
Q33791134-D72D8B2D-2D30-4557-8599-1BCC39FF6495Q33808410-CF33C07E-169B-465C-93F9-6B240DA16F90Q34633776-5DBB2ECE-690E-4CE2-9FE5-2B254D726EA1Q34704572-1D0CF33A-33AC-4F5B-B1C1-C76EBA48FF1BQ34819340-C41C0D17-1E43-4EBC-845D-03F8EE6E8B80Q34989490-EE9FF28A-925C-46F1-BD3D-0CA42A9E48C5Q35098797-349CA826-8435-43B3-AF40-4B1A432321A3Q35916867-FD09039C-4291-457C-8FAF-9EDEF025F9D9Q37280911-AD299B74-19BA-400A-9B44-C6FD1FE3A006Q38140004-89AC1C57-F319-46D0-AE1D-A3B47EDED432Q38728766-A41BAF24-3BDC-4F60-A1BE-4E3A5C1D9F5BQ39526971-43D5CFB5-1755-437C-A597-F602FBF8352BQ41050161-11966BEF-6842-4DE9-A0A3-AA144070CC36Q41065505-A10CA966-E1C1-4428-B6E7-AC3EC4A1E934Q43225619-5848D74B-BF26-45EE-9C8C-66FFD9B91C10Q51300105-BF7F769F-9B5C-4668-947D-9106B8D7578CQ51672964-032BD26F-BE8A-4F2F-A67D-58762B6DFED7Q52592894-E15CA2D1-4899-4556-905F-56E73A97D857Q52914437-4A9D48F1-1275-42BE-889E-9FD55D8132F9Q54961090-8EC07EE0-D265-496F-B0D7-9B444DE5C791
P2860
Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Neopterin as an indicator of i ...... th gynecological malignancies.
@ast
Neopterin as an indicator of i ...... th gynecological malignancies.
@en
type
label
Neopterin as an indicator of i ...... th gynecological malignancies.
@ast
Neopterin as an indicator of i ...... th gynecological malignancies.
@en
prefLabel
Neopterin as an indicator of i ...... th gynecological malignancies.
@ast
Neopterin as an indicator of i ...... th gynecological malignancies.
@en
P2093
P1476
Neopterin as an indicator of i ...... th gynecological malignancies.
@en
P2093
Freedman RS
Melichar B
Solichová D
P304
P356
10.1111/J.1525-1438.2006.00294.X
P577
2006-01-01T00:00:00Z